暫無數據
代碼股票名稱
最新價漲跌額漲跌幅成交量成交額今開昨收最高最低總市值流通市值總股本流通股本5日漲跌幅10日漲跌幅20日漲跌幅60日漲跌幅120日漲跌幅250日漲跌幅年初至今漲跌幅股息率TTM換手率市盈率TTM市盈率(靜)振幅所屬行業
美股市場個股詳情
GILD 吉利德科學
- 65.940
- +0.520+0.79%
收盤價 04/29 16:00 (美東)
- 66.490
- +0.550+0.83%
盤後 19:32 (美東)
821.61億總市值183.17市盈率TTM
66.910最高價65.200最低價783.85萬股成交量65.300今開65.420昨收5.18億成交額0.63%換手率14.65市盈率(靜)12.46億總股本86.97452周最高4.71市淨率820.52億流通值64.63052周最低3.02股息TTM12.44億流通股91.089歷史最高4.58%股息率TTM2.61%振幅0.414歷史最低66.143平均價1股每手
盤後分時
- 5日
- 日K
- 周K
- 月K
- 季K
- 年K
資金分布
單位: --
資金流向
實時日周月
暫無數據
新聞
吉利德科學期權聚焦：4月29日成交5.24萬張，未平倉合約為29.85萬張
美東時間4月29日，$吉利德科學(GILD.US)$期權成交活躍，當日期權總成交量達5.24萬張，其中認沽期權佔總成交量的19.76%，認購期權佔80.24%。數據顯示，截至當日收盤，$吉利德科學(GILD.US)$未平倉合約（即沒有買賣或行權的期權合約）總計約29.85萬張，與其近30個交易日均值比為125.01%。值得注意的是，在$吉利德科學(GILD.US)$成交價格為66.46 美元
巴克萊銀行將吉利德科學維持在同等權重
巴克萊銀行將吉利德科學維持在同等權重
吉利德科學分析師評級
日期上行/下行分析師公司目標股價變動評級變動之前/當前評級 2024 年 4 月 29 日 13.99% 巴克萊 80 美元 → 76 美元維持等權重 2024 年 4 月 26 日 27.49% 道明考恩 90 美元 → 85 美元維持不變
吉利德科學公司（GILD）是熱門股票：在下注之前需要了解的事實
快訊 | 吉利德：巴克萊將目標價格從80美元下調至76美元
吉利德科學：在市場挑戰和增長不確定性下，保持評級，前景謹慎
評論
Gilead Sciences Sees Deep-Pocketed Investors Take Bullish Stance, Benzinga Reports
Deep-pocketed investors have taken a bullish approach towards $吉利德科學(GILD.US$, Benzinga reported, cited nine extraordinary options activities linked to the stock. About 77% of the trades were leaning bullish and 22% bearish, according to the report.
Four of them were puts, totaling $495,628, and five were calls, amounting to $213,111, the report showed. The volume and open interest data on the contract...
Four of them were puts, totaling $495,628, and five were calls, amounting to $213,111, the report showed. The volume and open interest data on the contract...
煩，爲什麼要拋售好孩子。乳癌應該很快就大賺了
12 Biotech M&A deals in Q1 totaling $19 bil on similar pace with 2022...
$SPDR標普生物科技ETF(XBI.US$$生物科技指數ETF-iShares(IBB.US$
M&A in Q1 alone totaled 12 deals for $19.2 bil which is close to the 10 deals for $21.9 bil in all the 1H of 2023...
But one big caveat of this chart, it doesn't include $輝瑞(PFE.US$ 's $43 bil deal for $SGEN announced in Mar 2023 but didn't close until Dec bc of an FTC challenge,
The biggest biotech M&A deal so far this yr was $吉利德科學(GILD.US$ 's $4.3 b...
M&A in Q1 alone totaled 12 deals for $19.2 bil which is close to the 10 deals for $21.9 bil in all the 1H of 2023...
But one big caveat of this chart, it doesn't include $輝瑞(PFE.US$ 's $43 bil deal for $SGEN announced in Mar 2023 but didn't close until Dec bc of an FTC challenge,
The biggest biotech M&A deal so far this yr was $吉利德科學(GILD.US$ 's $4.3 b...
6
閱讀更多
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅
